The main objective of this trial is to evaluate the safety and reactogenicity of mRNA-1189 in 18- to 30-year-old healthy adults.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, learn about Clinical
|Ages Eligible for Study||Min Age: 18 Years - Max Age: 30 Years|
|Sexes Eligible for Study||All|
|Accepts Healthy Volunteers||Yes|